Share
PrintGenomic Medicine II
On Dec. 5-6, 2011, the National Human Genome Research Institute (NHGRI), sponsored its second Genomic Medicine Centers meeting - Genomic Medicine Centers Meeting II - at the Hyatt Regency Bethesda, Md. Rex Chisholm, Ph. D., Northwestern University, and Teri Manolio, M.D., Ph.D., NHGRI, co-chaired the meeting, which gathered genomics researchers, experts and professionals to:
- Develop ideas for multicenter collaborative pilot projects in translational genomic medicine
- Learn of new projects ongoing at partner sites
- Identify infrastructure needs and possible solutions to speed the adoption of genomic medicine
- Establish mechanisms for sharing of best practices among genomic medicine centers
Read the meeting minutes 
Available in the table below are videos and accompanying slides from the symposium.
Also available as a video playlist on GenomeTV
Monday, December 5, 2011
| 1 | Meeting Overview and Welcome
|
Rex Chisholm, Ph. D. Northwestern University |
| 2 | Remarks from NHGRI Director
|
Eric D. Green, M.D., Ph.D. National Human Genome Research Institute |
| 3 | Summary of Genomic Medicine I meeting in Chicago
|
Geoff Ginsburg, M.D., Ph.D. Duke Institute for Genome Sciences and Policy |
| 4 | Summary of Genomic Medicine I meeting in Chicago
|
Teri Manolio, M.D., Ph.D. National Human Genome Research Institute |
| 5 | Clinically Actionable Variants Meeting Summary
|
Marc Williams, M.D., F.A.A.P., F.A.C.M.G. Intermountain Healthcare |
| 6 | Institutional Leadership Perspectives on Implementing Genomic Medicine Programs
|
Bill Evans St. Jude Children's Research Hospital |
| 7 | Institutional Leadership Perspectives on Implementing Genomic Medicine Programs
|
Joann Wade Geisinger Health System |
| 8 | Potential Collaborative Opportunities - Colorectal, endometrial, neuroendocrine cancers
|
Charis Eng, M.D, Ph.D. Genomic Medicine Institute, Cleveland Clinic |
| 9 | Potential Collaborative Opportunities - Periodontal Microbiome
|
Murray Brilliant, Ph.D. Marshfield Clinic |
| 10 | Potential Collaborative Opportunities - Family History
|
Geoff Ginsburg, M.D., Ph.D. Duke Institute for Genome Sciences and Policy |
| 11 | Potential Collaborative Opportunities - Pharmacogenomics
|
Howard McCleod, PharmD University of North Carolina at Chapel Hill |
| 12 | Potential Collaborative Opportunities - 1200 Patients Project
|
Mark Ratain, M.D. University of Chicago |
| 13 | Potential Collaborative Opportunities - PAPI-2 Study
|
Alan Shuldiner, M.D. University of Maryland School of Medicine |
| 14 | Potential Collaborative Opportunities - Clinical Sequencing at Medical College of Wisconsin
|
Howard Jacob, Ph.D. Medical College of Wisconsin |
| 15 | Potential Collaborative Opportunities - Clinical Sequencing at University of Washington
|
Gail Jarvik, M.D., Ph.D. University of Washington, Seattle |
| 16 | Potential Collaborative Opportunities - CLIA-approved Sequencing, GENEINSIGHT
|
Scott Weiss, M.D., M.S. Harvard Medical School |
Tuesday, December 6, 2011
| 17 | Summary of the Previous Day
|
Rex Chisholm, Ph. D. Northwestern University Teri Manolio, M.D., Ph.D. National Human Genome Research Institute |
| 18 | Additional Genomic Medicine Projects - Scripps
|
Eric Topol, M.D. The Scripps Research Institute |
| 19 | Additional Genomic Medicine Projects - TGen
|
David Craig, Ph.D. The Translational Genomics Research Institute |
| 20 | Additional Genomic Medicine Projects - Veterans Affairs
|
Maren Scheuner, M.D., M.P.H. VA Greater Los Angeles Healthcare System |
| 21 | Genomic Medicine Programs at the NIH Clinical Center
|
William A. Gahl, M.D., Ph.D. National Human Genome Research Institute Leslie G. Biesecker, M.D. National Human Genome Research Institute |
| 22 | Presentation/Discussion of Pilot Demonstration Projects - Group 1 (Cancers)
|
Charis Eng, M.D, Ph.D. Genomic Medicine Institute, Cleveland Clinic |
| 23 | Presentation/Discussion of Pilot Demonstration Projects - Group 2 (Periodontal Microbiome)
|
Murray Brilliant, Ph.D. Marshfield Clinic |
| 24 | Presentation/Discussion of Pilot Demonstration Projects - Group 3 (Family History)
|
Geoff Ginsburg, M.D., Ph.D. Duke Institute for Genome Sciences and Policy |
| 25 | Presentation/Discussion of Pilot Demonstration Projects - Group 4 (Pharmacogenetics)
|
Alan Shuldiner, M.D. University of Maryland School of Medicine Howard McLeod University of North Carolina at Chapel Hill Mark Ratain, M.D. University of Chicago |
| 26 | Presentation/Discussion of Pilot Demonstration Projects - Group 5 (Sequencing)
|
Howard Jacob, Ph.D. Medical College of Wisconsin Scott Weiss, M.D., M.S. Harvard Medical School |
| 27 | Presentation/Discussion of Pilot Demonstration Projects - Group 6 (Miscellanea)
|
Marc Williams, M.D., F.A.A.P., F.A.C.M.G. Intermountain Healthcare |
| 28 | Navigating the Boundaries between Research and Clinical Care (Panel Discussion)
|
Pearl O'Rourke Partners Healthcare Systems |
| 29 | Navigating the Boundaries between Research and Clinical Care (Panel Discussion)
|
David Chambers |
| 30 | Navigating the Boundaries between Research and Clinical Care (Panel Discussion)
|
David Ledbetter, Ph.D. Emory University |
| 31 | Navigating the Boundaries between Research and Clinical Care (Panel Discussion)
|
Erwin Bottinger, M.D. The Mount Sinai Hospital |
| 32 | Navigating the Boundaries between Research and Clinical Care (Q&A Session)
|
Pearl O'Rourke (Moderator) Partners Healthcare Systems |
| 33 | Plans for May Meeting and Subsequent Meetings
|
Dan Roden, M.D. Vanderbilt Medical Center |
| 34 | Next Steps for Demonstration Projects
|
Rex Chisholm, Ph.D. Northwestern University |
To view the PDF document(s) on this page, you will need Adobe Reader. 
Last Reviewed: May 8, 2012
Leave a Comment!
We encourage you to share your thoughts as they relate to the topics being discussed on genome.gov, other websites or discussion forums owned or administered by the National Human Genome Research Institute (NHGRI). We review all comments for posting. We do not discriminate against any views, but we reserve the right not to post comments, or to remove comments, that are inconsistent with our Comment Policy, at our complete discretion.
Comments:
No comments yet. Be the first!
